Jim Tartaglia

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan et al. · New England Journal of Medicine · 2009 · 3K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +12

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Denis Gaucher, René Therrien, Nadia Kettaf et al. · The Journal of Experimental Medicine · 2008 · 597 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

Nicos Karasavvas, Erik Billings, Mangala Rao et al. · AIDS Research and Human Retroviruses · 2012 · 215 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Merlin L. Robb, Supachai Rerks‐Ngarm, Sorachai Nitayaphan et al. · The Lancet Infectious Diseases · 2012 · 215 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

Monica Vaccari, Shari N. Gordon, Slim Fourati et al. · Nature Medicine · 2016 · 204 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16